|
|
Article: Cord Blood Registry Wins Legal Battle in Patent Dispute With PharmaStem Therapeutics, Inc. Largest Newborn Stem Cell Bank Announces Victory in Delaware Patent Case.
- Article from:
- PR Newswire
- Article date:
- September 20, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN BRUNO, Calif., Sept. 20 /PRNewswire/ -- Cord Blood Registry(TM)-CBR, the nation's leading newborn stem cell bank, announced today that it has won a decisive legal victory against PharmaStem Therapeutics, Inc.'s attempts to assert claims for alleged patent infringement relating to the cryopreservation of newborn "cord blood" stem cells.
In Delaware on September 15, 2004, U.S. District Court Judge Gregory Sleet issued an Order and Judgment, overturning the jury verdict against CBR that was entered in October 2003. The Court found that "there is simply no evidence in the record to support the jury's affirmative answer" that CBR infringed on a patent claimed ...